Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.21.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Stock Option Outstanding, Beginning Balance 99,833 94,553
Stock Option Outstanding, Granted 3,000,000 5,280
Stock Option Outstanding, Cancelled (85,753)
Stock Option Outstanding, Exercised
Stock Option Outstanding, Ending Balance 3,014,080 99,833
Stock Option Outstanding, Exercisable Ending Balance 514,080  
Weighted Average Exercise Price, Beginning Balance $ 27.81 $ 28.71
Weighted Average Exercise Price, Granted 0.15 11.60
Weighted Average Exercise Price, Cancelled 23.53
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending Balance 0.37 $ 27.81
Weighted Average Exercise Price, Exercisable Ending Balance $ 1.46  
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 2 years 7 days 2 years 11 months 8 days
Weighted Average Remaining Contractual Term (years), Granted 1 year 7 months 24 days 3 years 4 months 17 days
Weighted Average Remaining Contractual Term (years), Cancelled 8 months 5 days  
Weighted Average Remaining Contractual Term (years), Outstanding Ending 1 year 8 months 2 days  
Weighted Average Remaining Contractual Term (years), Exercisable 1 year 9 months 3 days  
Aggregated Intrinsic Value, Outstanding Ending  
Aggregated Intrinsic Value, Exercisable Ending